Cancerology Master Degree

At the time of its creation in 2013, the Master’s program in Oncology was the first program in France to bear the “Oncology” heading.    
For more information on this program please visit the dedicated UCBL website.

The first year of the Master’s program (M1) aims at providing students with a solid scientific background to enable them to follow one of the three specialised second year programs (M2). The M1 course comprises 30 mandatory credits (“Unités d’Enseignements” UEs or “European Credit Transfer and Accumulation System” ECTS) in the first semester and 24 in the second semester, including 12 research training credits and 6 optional or open-choice credits.

In the second year of the Master’s program (M2), three specialised courses are available:

- Biology of Cancer. This course revolves around 3 taught semesters (S3) and includes a research training period accounting for 21 credits, 6 optional or open-choice credits, and 3 English course credits “preparing for a symposium”. The fourth semester (S4) is based on a training period accounting for 24 credits and 6 optional UE or open-choice credits. The duration of the research training period exceeds 6 months. Medical students or engineers can integrate this M2 course following an M1 in Biomedical Research, after a LADMET M1, after having completed their final (5th) year in an engineering school, or following consent in the event that they are still in their 5th year.

- Innovative Therapeutics in Oncology. This course is based on 3 taught semesters (S3) includes a research training period accounting for 21 credits, a mandatory UE accounting for 6 credits and an optional or open-choice UE of 3 credits. The fourth semester (S4) involves a training period accounting for 24 credits and 6 optional UE or open-choice credits. The duration of the research training period exceeds 6 months. Medical students or engineers can integrate this M2 course following an M1 in Biomedical Research, after a LADMET M1, after having completed their final (5th) year in an engineering school, or following consent in the event that they are still in their 5th year.

- Omics Approaches in Oncology. This course also involves 3 taught semesters, including a research training period accounting for 21 credits, a mandatory UE accounting for 6 credits and an optional or open-choice UE of 3 credits. The fourth semester (S4) is dedicated to a training period accounting for 24 credits and 6 optional UE or open-choice credits. The duration of the research training period exceeds 6 months. Medical students or engineers can integrate this M2 course following an M1 in Biomedical Research, after a LADMET M1, after having completed their final (5th) year in an engineering school, or following consent in the event that they are still in their 5th year.

CENTRE DE RECHERCHE EN CANCEROLOGIE DE LYON (CRCL)
UMR INSERM 1052 CNRS 5286 - CENTRE LEON BERARD
Copyright 2011. CRCL
SUIVEZ LES ACTUALITES
DU CRCL SUR TWITTER :